Baird Melissa's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Dec 6, 2023
- Accession no.
- 0001773751-23-000286
- Filed
- Dec 6, 2023, 6:41 PM ET
- Trade date
- Dec 4-6, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $243.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baird MelissaCIK 0001837815 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2023 | Class A Common Stock | MOption exerciseAcquired | +3,624 | $0.40 | +$1,449.6 | 407,473 | Direct | |
| Dec 4, 2023 | Class A Common Stock | SSaleDisposed | −9,133 | $8.81F3 | −$80,485.48 | 400,840 | Direct | |
| Dec 5, 2023 | Class A Common Stock | SSaleDisposed | −9,133 | $8.78F4 | −$80,220.62 | 391,707 | Direct | |
| Dec 6, 2023 | Class A Common Stock | SSaleDisposed | −9,133 | $9.02F5 | −$82,402.49 | 382,574 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2023 | Class A Common Stock | MOption exerciseDisposed | −3,624 | $0.00 | $0 | 810,664 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.65 - $8.915. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.64 - $8.845. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $8.88 - $9.22. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.